Table of Contents Author Guidelines Submit a Manuscript
Journal of Healthcare Engineering
Volume 4 (2013), Issue 4, Pages 453-464
Research Article

Hemodynamic Sensor in Cardiac Implantable Electric Devices: The Endocardial Accelaration Technology

Stefania Sacchi,1 Danilo Contardi,3 Paolo Pieragnoli,1 Giuseppe Ricciardi,1 Andrea Giomi,1 and Luigi Padeletti1,2

1Istituto di Clinica Medica e Cardiologia, University of Florence, Italy
2Cliniche Gavazzeni, Bergamo, Italy
3SORIN Group Italia S.r.l., Milano, Italy

Received 1 January 2013; Accepted 1 July 2013

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. McMurray, S. Adamopoulos, S. D. Anker et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC,” Eur Heart J, vol. 33, pp. 1787–1847, 2012. View at Google Scholar
  2. M. O. Sweeney, “Peak endocardial acceleration signals for atrial mechanical activation,” J Cardiovasc Electrophysiol, vol. 22, pp. 584–586, 2011. View at Google Scholar
  3. K. Kadhiresan and G. Carlson, “The role of implantable sensors for management of heart failure,” Stud Health Technol Inform, vol. 108, pp. 219–227, 2004. View at Google Scholar
  4. L. Antonini, A. Auriti, V. Pasceri et al., “Optimization of the atrioventricular delay in sequential and biventricular pacing: physiological bases, critical review, and new purposes,” Europace, vol. 14, pp. 929–938, 2012. View at Google Scholar
  5. T. Bombardini, G. Gaggini, E. Marcelli, M. Parlapiano, and G. Plicchi, “Peak Endocardial Acceleration reflects heart Contractility Also in Atrial Fibrillation,” Pacing Clin Electrophysiol, vol. 23, no. 9, pp. 1381–1385, 2000. View at Google Scholar
  6. M. G. Bongiorni, E. Soldati, G. Arena et al., “Is local myocardial contractility related to endocardial acceleration signals detected by a transvenous pacing lead?” Pacing Clin Electrophysiol, vol. 19, pp. 1682–1688, 1996. View at Google Scholar
  7. A. F. Rickards, T. Bombardini, G. Corbucci, G. Plicchi, and for the Multicenter PEA Study Group, “An implantable intracardiac accelerometer for monitoring myocardial contractility,” Pacing Clin Electrophysiol, vol. 19, pp. 2066–2071, 1996. View at Google Scholar
  8. G. Plicchi, E. Marcelli, M. Parlapiano, and T. Bombardini, “PEA I and PEA II based implantable hemodynamic monitor: Pre Clinical studies in sheep,” Europe, vol. 4, pp. 49–54, 2002. View at Google Scholar
  9. P. Bordachar, S. Garrigue, P. Ritter et al., “Contributions of a hemodynamic sensor embedded in an atrial lead in a porcine model,” J Cardiovasc Electrophysiol, vol. 22, pp. 579–583, 2011. View at Google Scholar
  10. D. Gras, L. Kubler, P. Ritter et al., “Recording of Peak Endocardial Acceleration in the atrium,” PACE, vol. 32, pp. S240–S246, 2009. View at Google Scholar
  11. W. L. Gleason and E. Braunwald, “Studies on the first derivative of the left ventricular pressure pulse in man,” J Clin Invest, vol. 41, pp. 80–84, 1962. View at Google Scholar
  12. D. T. Mason, “Usefulness and limitations of the rate of rise of intraventricular pressure (dP/dt) in the evolution of myocardial contractility in man,” Am J Cardiol, vol. 23, pp. 516–527, 1969. View at Google Scholar
  13. A. Tassin, A. Kobeissi, L. Vitali et al., “Relationship between amplitude and timing of hearts sounds and endocardial acceleration,” Pacin Clin Electrophysiol, vol. 32, (Suppl.1), pp. S101–S104, 2009. View at Google Scholar
  14. J. Clementy, A. Kobeissi, S. Garrigue, P. Jaïs, P. Le Metayer, and M. Haïssaguerre, “Validation by serial standardized testing of a new rate-responsive pacemaker sensor based on variations in myocardial contractility,” Europace, vol. 3, pp. 124–131, 2001. View at Google Scholar
  15. J. Clementy, S. Garrigue, A. Le Mouroux, G. Gaggini, and on behalf of the European PEA Clinical Investigation Group, “Dual-chamber rate responsive pacing system driven by contractility: short-term study and final assessment after one-year follow-up,” in Progress in Clinical Pacing, Proceedings Book, Chapter 33, pp. 219–224, 1998. View at Google Scholar
  16. E. M. Greco, M. Ferrario, and S. Romano, “Clinical evaluation of peak endocardial acceleration as a sensor for rate-responsive pacing,” PACE, vol. 26, (Pt 1), pp. 812–818, 2003. View at Google Scholar
  17. D. Kasinski, B. P. Grubb, and P. Temesy-Armos, “Pathological aspects of neurocardiogenic syncope: current concepts and new perspectives,” Pacing Clin Electrophysiol, vol. 18, pp. 716–24, 1995. View at Google Scholar
  18. J. C. Deharo, J. P. Peyre, T. Chalvidan et al., “Continuous monitoring of an endocardial index of myocardial contractility during head-up tilt test,” Am Heart J, vol. 139, no. 6, pp. 1022–1030, 2000. View at Google Scholar
  19. L. Mangin, A. Kobeissi, D. Lelouche et al., “Simultaneous analysis of heart rate variability and myocardial contractility during head-up tilt in patients with vasovagal syncope,” J Cardiovasc Electrophysiol, vol. 12, no. 6, pp. 639–644, 2001. View at Google Scholar
  20. J. C. Deharo, A. Borri-Brunetto, F. Bellocci et al., “DDDR pacing driven by contractility versus DDI pacing in vasovagal syncope: a multicenter, randomized study,” Pacing Clin Electrophysiol, vol. 26, no. 1, Pt 2, pp. 447–550, 2003. View at Google Scholar
  21. P. Ritter, L. Padeletti, L. Gillio-Meina, and G. Gaggini, “Determination of the optimal atrioventricular delay in DDD pacing Comparison between echo and peak endocardial acceleration measurements,” Europace, vol. 1, pp. 126–130, 1999. View at Google Scholar
  22. S. K. Leung, C. P. Lau, C. T. Lam et al., “Automatic optimization of resting and exercise atrioventricular interval using a peak endocardial acceleration sensor: validation with Doppler echocardiography and direct cardiac output measurements,” Pacing Clin Electrophysiol, vol. 23, no. 11, Pt 2, pp. 1762–1766, 2000. View at Google Scholar
  23. F. A. Cuoco and M. R. Gold, “Optimization of cardiac resynchronization therapy: importance of programmed parameters,” J Cardiovasc Electrophysiol, vol. 23, no. 1, pp. 110–118, 2012. View at Google Scholar
  24. W. Mullens, R. A. Grimm, T. Verga et al., “Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program,” J Am Coll Cardiol, vol. 53, no. 9, pp. 765–773, 2009. View at Google Scholar
  25. P. P. Delnoy, E. Marcelli, H. Oudeluttikhuis et al., “Validation of a peak endocardial acceleration-based algorithm to optimize cardiac resynchronization: early clinical results,” Europace, vol. 10, no. 7, pp. 801–808, 2008. View at Google Scholar
  26. J. M. Dupuis, A. Kobeissi, L. Vitali et al., “Programming optimal atrioventricular delay in dual chamber pacing using Endocardial Acceleration: comparison with a standard echocardiographic procedure,” PACE, vol. 26, (Pt. II), pp. 210–213, 2003. View at Google Scholar
  27. P. Ritter, P. P. Delnoy, L. Padeletti et al., “A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods,” Europace, vol. 14, no. 9, pp. 1324–1333, 2012. View at Google Scholar
  28. RESPOND-CRT, id: NCT01534234,
  29. E. Donal, L. Giorgis, S. Cazeau et al., “Endocardial acceleration (sonR) vs. ultrasound-derived time intervals in recipients of cardiac resynchronization therapy system,” Europace, vol. 13, no. 3, pp. 402–8, 2011. View at Google Scholar
  30. M. Bertini, V. Delgrado, J. J. Bax, and N. R. L. Van de Veire, “Why, how and when do we need to optimize the setting of cardiac resynchronization therapy?” Europace, vol. 11, pp. v46–v57, 2009. View at Google Scholar
  31. K. A. Ellenbogen, M. R. Gold, T. E. Meyer et al., “Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy,” Circulation, vol. 122, no. 25, pp. 2660–8, 2010. View at Google Scholar
  32. W. T. Abraham, D. Gras, C. M. Yu, L. Guzzo, and M. S. Gupta, “MS; FREEDOM Steering Committee. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial,” Am Heart J, vol. 159, no. 6, pp. 944–948, 2010. View at Google Scholar
  33. M. C. Porciani, I. Ricceri, P. Attanà et al., “Discordant electrical and mechanical atrial delays affect intracavitary electrograms-based cardiac resynchronization therapy optimization,” Europace, vol. 14, no. 4, pp. 593–8, 2012. View at Google Scholar